{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:34:03Z","timestamp":1763793243940,"version":"3.45.0"},"reference-count":20,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["NIHR200182","NIHR202484"],"award-info":[{"award-number":["NIHR200182","NIHR202484"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,11,3]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the safety of implementing structured medication optimisation reviews (SMORs) for patients with atrial fibrillation (AF) prescribed direct oral anticoagulants (DOACs). SMORs aimed to improve quality of care and facilitate large-scale alignment with national prescribing guidance (to switch patients onto edoxaban).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Complex intervention including a SMOR embedded within primary care electronic patient records alongside clinical decision support tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Doubly robust difference-in-difference analysis using linked electronic health records, comparing changes in prescribing and bleeding admissions in patients undergoing SMOR with those in patients not reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Sefton (intervention area) and Liverpool (comparator area) in the Northwest of England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All patients with AF prescribed a DOAC in 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures<\/jats:title>\n                    <jats:p>Proportion of patients prescribed apixaban, proportion of patients prescribed edoxaban and rate of emergency hospital admissions for bleeding-related events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The proportion of patients in Sefton prescribed edoxaban increased from 19% to 35%; 13% (95% CI 11% to 14%) of the increase was associated with the SMOR. There was an 11-percentage point decrease in patients prescribed apixaban (95%\u2009CI \u221212% to \u221210%). Undergoing review was associated with a non-significant reduction in the risk of bleeding admissions (eight fewer admissions per 1000 people reviewed per year; 95%\u2009CI \u221222 to 6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SMORs can be delivered at scale and used to switch medications for a large proportion of people. There was no evidence of an increased risk of admissions for bleeding complications in AF patients following a large-scale switch from apixaban to edoxaban supported by SMORs. Such reviews could improve prescribing quality and patient safety by ensuring patients are on the most appropriate dose and choice of DOAC and lead to cost savings to health services (by facilitating a switch to a better value product) while not increasing risks for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjoq-2025-003568","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:30:16Z","timestamp":1763793016000},"page":"e003568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the impact of a structured medication optimisation review on prescribing patterns and bleeding risk among patients prescribed direct oral anticoagulants (DOACs): a difference-in-differences study"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-7710","authenticated-orcid":false,"given":"Elizabeth M","family":"Camacho","sequence":"first","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olly","family":"Butters","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Daras","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Downing","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Bateman","sequence":"additional","affiliation":[{"name":"Countess of Chester Hospital NHS Foundation Trust, Chester, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Lynch","sequence":"additional","affiliation":[{"name":"NHS Cheshire and Merseyside Integrated Care Board, Warrington, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-1650","authenticated-orcid":false,"given":"Iain Edward","family":"Buchan","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Barr","sequence":"additional","affiliation":[{"name":"Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2025112122301120000_14.4.e003568.1","unstructured":"Public health profiles. Available: http:\/\/fingertips.phe.org.uk\/profile\/national-child-measurement-programme\/data#gid\/8000011\/pat\/6\/ati\/102\/page\/9\/par\/E12000004\/are\/E06000015 [Accessed 9 Apr 2014]."},{"key":"2025112122301120000_14.4.e003568.2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025112122301120000_14.4.e003568.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033357","article-title":"Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study","volume":"10","author":"Alfirevic","year":"2020","journal-title":"BMJ Open"},{"key":"2025112122301120000_14.4.e003568.4","unstructured":"NHS England . Thousands of lives saved by the nhs thanks to rapid rollout of blood thinners. Available: https:\/\/www.england.nhs.uk\/2023\/11\/thousands-of-lives-saved-by-the-nhs-thanks-to-rapid-rollout-of-blood-thinners\/ [Accessed 11 Mar 2024]."},{"key":"2025112122301120000_14.4.e003568.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317006"},{"key":"2025112122301120000_14.4.e003568.6","unstructured":"NHS England . Commissioning recommendations for the national procurement of direct acting oral anticoagulants (doacs). Available: https:\/\/www.england.nhs.uk\/publication\/commissioning-recommendations-for-the-national-procurement-of-direct-acting-oral-anticoagulants-doacs\/ [Accessed 30 Jan 2023]."},{"key":"2025112122301120000_14.4.e003568.7","unstructured":"NHS England . Network contract directed enhanced service \u2013 investment and impact fund 2022\/23 summary. Available: https:\/\/www.england.nhs.uk\/publication\/network-contract-directed-enhanced-service-investment-and-impact-fund-2022-23-summary\/ [Accessed 30 Jan 2023]."},{"key":"2025112122301120000_14.4.e003568.8","unstructured":"Ministry of Housing C& LG . English indices of deprivation 2019: research report. 2019. Available: https:\/\/www.gov.uk\/government\/publications\/english-indices-of-deprivation-2019-research-report"},{"key":"2025112122301120000_14.4.e003568.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"2025112122301120000_14.4.e003568.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"2025112122301120000_14.4.e003568.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv476"},{"key":"2025112122301120000_14.4.e003568.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jeconom.2020.06.003"},{"key":"2025112122301120000_14.4.e003568.13","unstructured":"Wooldridge JM . Introductory Econometrics: A Modern Approach. 5th edn. CENGAGE Learning Custom Publishing, 2012."},{"key":"2025112122301120000_14.4.e003568.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy136"},{"key":"2025112122301120000_14.4.e003568.15","unstructured":"National Institute of Health and Care Excellence (NICE) . NICE Guidel. Atrial fibrillation: diagnosis and management [NG196], Available: https:\/\/www.nice.org.uk\/guidance\/ng196"},{"key":"2025112122301120000_14.4.e003568.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.06.114"},{"key":"2025112122301120000_14.4.e003568.17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2021.11.008","article-title":"Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study","volume":"346","author":"Marston","year":"2022","journal-title":"Int J Cardiol"},{"key":"2025112122301120000_14.4.e003568.18","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0511"},{"key":"2025112122301120000_14.4.e003568.19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1125576","article-title":"Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study","volume":"14","author":"Grymonprez","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025112122301120000_14.4.e003568.20","unstructured":"NHS England . Commissioning recommendations for national procurement for direct-acting oral anticoagulant(s) (doacs). 2024. Available: https:\/\/www.england.nhs.uk\/long-read\/commissioning-recommendations-for-national-procurement-for-doacs"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2025-003568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:30:23Z","timestamp":1763793023000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2025-003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,21]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjoq-2025-003568"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2025-003568","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}